Brawn Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Brawn Biotech Ltd · Outcome · 05 Nov 2026, 8:02 pm
Brawn Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 562 (+15.0% YoY | -7.5% QoQ) ■ EBITDA: -8.0 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -1.4 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: 3.0 (-57.6% YoY | -80.4% QoQ) ■ EPS (INR): 0.12 (-52.0% YoY | -76.9% QoQ)
Original exchange filing (PDF)
More announcements from Brawn Biotech Ltd
- Intimation regarding non-applicability of regulation 23(9) · 05 Nov 2026
- Outcome of Board Meeting · 05 Nov 2026
- Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... · 05 Nov 2026
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 · 29 Sept 2026
- Scrutinizers Report attached along with voting results for 41st AGM · 29 Sept 2026
- Proceedings of 41st AGM · 29 Sept 2026
- Outcome of 41st Annual General Meeting · 29 Sept 2026
- Letters sent to shareholders as per Reg 36 · 02 Sept 2026
